...13%) to $8.76 on Wednesday. Repligen raises $370M via sales of stock, notes Bioprocessing company Repligen Corp....
...million shares at $87 in an upsized follow-on. The price is a 1.2% premium to Repligen’s...
...CMS, joined its board. Undisclosed other investors participated in the financing. Hongjiang Li, Staff Writer AVR-RD-01, avr-02 Avrobio Inc. Repligen Corp. Seer...

...NASDAQ:VCYT) 5/2/19 $147.1 $1,112.1 $1,363.8 23% Magenta Therapeutics Inc. (NASDAQ:MGTA) 5/1/19 $64.8 $520.6 $496.4 -5% Repligen Corp....

...Repligen raises $175M follow-on Bioprocessing company Repligen Corp. (NASDAQ:RGEN) raised $175 million through the sale of 2.7...
...in a private placement through the sale of 5.6 million shares at $8.50. Brian Moy, Assistant Editor Repligen Corp. Translate...

...their own production. Ransohoff is a chemical engineer who conducted GMP manufacturing at Xoma and Repligen Corp....
...NYSE:NVS; SIX:NOVN), Basel, Switzerland Orchard Therapeutics plc (NASDAQ:ORTX), London, U.K. RegenxBio Inc. (NASDAQ:RGNX), Rockville, Md. Repligen Corp....

...with vehicle. Next steps could include testing inhibitors of DCPS in additional models of AML. Repligen Corp....

...BioMarin acquired the candidate from Repligen Corp. (NASDAQ:RGEN) in 2014. Chris Lieu BioMarin Pharmaceutical Inc. Cincinnati Children's Hospital Medical Center Repligen Corp. Histone...

...implications for the bioprocessing company. GE Healthcare is a unit of General Electric Co. (NYSE:GE). Repligen...
...Couillard said the long-term implications on Repligen's financial outlook are "hard to ignore," especially if Repligen's...
...of Repligen's 2016 revenues. Repligen reported revenues of $104.5 million in 2016. Elizabeth S. Eaton General Electric Co. Repligen Corp. MabSelect...

...NASDAQ:BLUE) 6/27/17 $400.1 $4,699.8 $4,702.1 0% Neos Therapeutics Inc. (NASDAQ:NEOS) 6/27/17 $32.4 $184.7 $199.7 8% Repligen Corp....

...On June 27, bioprocessing company Repligen Corp. (NASDAQ:RGEN) raised $120 million through the sale of 2.8 million...
...follow-on underwritten by JPMorgan, Stephens, Janney Montgomery Scott and Craig-Hallum Capital. Repligen Corp. (NASDAQ:RGEN), Waltham, Mass. Alicia Parker Repligen Corp....